314 related articles for article (PubMed ID: 34350177)
1. Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
Wu Y; Liang X; Ni J; Zhao R; Shao S; Lu S; Han W; Yu L
Front Cell Dev Biol; 2021; 9():681240. PubMed ID: 34350177
[No Abstract] [Full Text] [Related]
2. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
3. Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1.
Zhou X; Zhang K; Wang C; Teng Y; Yu P; Cai W; Gao W; Li M; Ding Y; Sun P; Chen F; Wang Y; Ma J; Maeshige N; Ma X; Li Q; Liang X; Zhang Y; Su D
Cancer Lett; 2024 May; 590():216868. PubMed ID: 38593920
[TBL] [Abstract][Full Text] [Related]
4. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
5. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
[TBL] [Abstract][Full Text] [Related]
6. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
9. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
10. A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer.
Gao H; Liang J; Duan J; Chen L; Li H; Zhen T; Zhang F; Dong Y; Shi H; Han A
Front Oncol; 2021; 11():638099. PubMed ID: 34211835
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
12. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
[TBL] [Abstract][Full Text] [Related]
13. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
Zheng Y; Zheng Y; Lei W; Xiang L; Chen M
Mol Cell Probes; 2019 Dec; 48():101445. PubMed ID: 31513891
[TBL] [Abstract][Full Text] [Related]
14. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.
Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA
Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625
[TBL] [Abstract][Full Text] [Related]
15. Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients.
Zhao ZX; Liu QL; Yuan Y; Wang FS
World J Gastrointest Oncol; 2022 Nov; 14(11):2122-2137. PubMed ID: 36438706
[TBL] [Abstract][Full Text] [Related]
16. High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study.
Li P; Sun J; Ruan Y; Song L
PeerJ; 2021; 9():e11551. PubMed ID: 34141488
[TBL] [Abstract][Full Text] [Related]
17. Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway
Chen P; Du R; Chang Z; Gao W; Zhao W; Dong G
J Gastrointest Oncol; 2023 Apr; 14(2):980-996. PubMed ID: 37201092
[TBL] [Abstract][Full Text] [Related]
18. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
19. Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer.
Liu C; Hu C; Li J; Jiang L; Zhao C
Front Mol Biosci; 2021; 8():633951. PubMed ID: 33898515
[No Abstract] [Full Text] [Related]
20. UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
Zhao YL; Zhong SR; Zhang SH; Bi JX; Xiao ZY; Wang SY; Jiao HL; Zhang D; Qiu JF; Zhang LJ; Huang CM; Chen XL; Ding YQ; Ye YP; Liang L; Liao WT
Cancer Cell Int; 2019; 19():126. PubMed ID: 31110467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]